Third Wave Technologies wants its Invader technology to be as ubiquitous as PCR. Since a deal with potential buyer Applera fell through two years ago, the company has begun several high-profile collaborations, including one with the Japanese SNP initiative, which now accounts for 50% of revenues. Its efforts appear to be paying off, but the company is fighting an uphill battle in an intensely competitive field.
by Wendy Diller
With some fanfare, PE Biosystems Inc., a business unit of PE Corp., agreed in January 2000 to buy Third Wave...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights